Different Prasugrel Administration in STEMI Patients Go Faster and No Fear to Crush!

Journal of the American College of Cardiology

Volumn 67, Issue 17, 2016, Pages 2005-2007

  Sardella, Gennaro ^a   Calcagno, Simone ^a   Mancone, Massimo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

crushed tablet; pharmacodynamic; pharmacokinetic; platelets

Indexed keywords

ANTITHROMBOCYTIC AGENT; CANGRELOR; CLOPIDOGREL; DRUG METABOLITE; MORPHINE; PRASUGREL; TICAGRELOR; PURINERGIC P2Y RECEPTOR ANTAGONIST; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ADD ON THERAPY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; HUMAN; LOADING DRUG DOSE; NOTE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PILL; PLATELET REACTIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TABLET;

HUMANS; PLATELET AGGREGATION INHIBITORS; PRASUGREL HYDROCHLORIDE; PURINERGIC P2Y RECEPTOR ANTAGONISTS; ST ELEVATION MYOCARDIAL INFARCTION; TICLOPIDINE;

EID: 84961285356     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.02.046     Document Type: Editorial

References (15)

1. D. Alexopoulos, G. Makris, I. Xanthopoulou, and et al. Onset of antiplatelet action with high (100 mg) versus standard (60 mg) loading dose of prasugrel in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: pharmacodynamic study Circ Cardiovasc Interv 7 2014 233 239
2. S.D. Wiviott, E. Braunwald, C.H. McCabe, et al. for the TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
3. L. Wallentin, R.C. Becker, A. Budaj, et al. for the PLATO Investigators Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
4. P.T. O'Gara, F.G. Kushner, D.D. Ascheim, and et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 61 2013 e78 e140
5. P.G. Steg, S.K. James, D. Atar, and et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology (ESC) Eur Heart J 33 2012 2569 2619
6. G. Parodi, R. Valenti, B. Bellandi, and et al. Comparison of prasugrel and ticagrelor loading doses in st-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) Primary PCI Study J Am Coll Cardiol 61 2013 1601 1606
7. F. Franchi, F. Rollini, J.R. Cho, and et al. Impact of escalating loading dose regimens of ticagrelor in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of a prospective randomized pharmacokinetic and pharmacodynamic investigation J Am Coll Cardiol Intv 8 2015 1457 1467
8. D. Alexopoulos, V. Gkizas, S. Patsilinakos, and et al. Double versus standard loading dose of ticagrelor: onset of antiplatelet action in patients with STEMI undergoing primary PCI J Am Coll Cardiol 62 2013 940 941
9. G. Parodi, I. Xanthopoulou, B. Bellandi, and et al. Ticagrelor crushed tablets administration in STEMI patients: the MOJITO study J Am Coll Cardiol 65 2015 511 512
10. D. Alexopoulos, N. Barampoutis, V. Gkizas, and et al. Crushed versus integral tablets of ticagrelor in st-segment elevation myocardial infarction patients: a randomized pharmacokinetic/pharmacodynamic study Clin Pharmacokinet 55 2016 359 367
11. F. Rollini, F. Franchi, J. Hu, and et al. Crushed prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary intervention: the CRUSH study J Am Coll Cardiol 67 2016 1994 2004
12. G. Parodi, B. Bellandi, I. Xanthopoulou, and et al. Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention Circ Cardiovasc Interv 8 2015 e001593
13. A.A. Heestermans, J.W. van Werkum, D. Taubert, and et al. Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction Thromb Res 122 2008 776 781
14. P.G. Steg, D.L. Bhatt, C.W. Hamm, and et al. Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data Lancet 382 2013 1981 1992
15. P.G. Steg, A. van't Hof, C.W. Hamm, and et al. Bivalirudin started during emergency transport for primary PCI N Engl J Med 369 2013 2207 2217